<--- Back to Details
First PageDocument Content
Anxiety disorders / Pharmacology / Amines / Eli Lilly and Company / Serotonin–norepinephrine reuptake inhibitor / Antidepressant / Food and Drug Administration / Venlafaxine / Fibromyalgia / Medicine / Psychiatry / Health
Date: 2014-11-29 17:18:39
Anxiety disorders
Pharmacology
Amines
Eli Lilly and Company
Serotonin–norepinephrine reuptake inhibitor
Antidepressant
Food and Drug Administration
Venlafaxine
Fibromyalgia
Medicine
Psychiatry
Health

Kentucky Department for Medicaid Services

Add to Reading List

Source URL: chfs.ky.gov

Download Document from Source Website

File Size: 30,92 KB

Share Document on Facebook

Similar Documents

Recommended Websites Anxiety Families Anxiety Disorders Association of Ontario

DocID: 1vhFb - View Document

M D A O | Quick Facts Anxiety and Mood Disorders What is anxiety? Social Phobia

DocID: 1veUF - View Document

Recommended Websites Anxiety Families Anxiety Disorders Association of Ontario

DocID: 1v0je - View Document

PRACTICE GUIDELINE FOR THE PHARMACOLOGICAL TREATMENT OF ANXIETY DISORDERS IN THE ELDERLY Chittaranjan Andrade1, Saifuddin Kharawala2 INTRODUCTORY NOTES 1.

DocID: 1rFWj - View Document

TIPS & INFORMATION Anxiety Anxiety disorders and how to cope Like many other illnesses, anxiety disorders often have an underlying biological cause and frequently run in families. These disorders can be treated by severa

DocID: 1ryOs - View Document